Dr. Beata Małecka-Libera, chairwoman of the Senate Health Committee, talks about the challenges in hematooncology.
Hematooncology is the kind of field where we see a constant increase in new molecules, but also a constant increase in patient needs. What does this look like from your perspective? What is the most pressing need for hematooncology patients right now?
Treatments, innovative therapies for hematooncology are important, but I, however, look at it all as oncological conditions, and as a systemicist I see the need to solve the problem from start to finish. So,...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
